Vir Biotechnology Inc (VIR)
Debt-to-assets ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 1,919,060 | 2,044,900 | 2,243,870 | 2,665,940 | 2,802,090 | 2,695,970 | 2,618,990 | 2,887,130 | 1,954,270 | 1,210,210 | 1,057,580 | 1,135,580 | 918,761 | 943,259 | 672,238 | 477,114 | 512,071 | 422,642 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,919,060K
= 0.00
Based on the data provided for Vir Biotechnology Inc, the debt-to-assets ratio has been consistently reported as 0.00 across all quarters from Q1 2022 to Q4 2023. A debt-to-assets ratio of 0.00 indicates that the company has not utilized any debt to finance its assets during these quarters. This can suggest that the company has been funding its operations and investments primarily through equity or other non-debt sources.
A debt-to-assets ratio of 0.00 may be viewed positively by investors and creditors as it signifies lower financial risk associated with debt obligations. However, it is essential to consider the context and industry norms when interpreting this ratio, as certain industries may typically have higher or lower debt levels. Further analysis of the company's overall financial health, liquidity position, and future capital structure strategy would provide a more comprehensive understanding of its financial standing.
Peer comparison
Dec 31, 2023